NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 45 filers reported holding NEOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $24,000 | +14.3% | 39,100 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -22.2% | 39,100 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | -6.9% | 39,100 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -50.8% | 39,100 | 0.0% | 0.00% | – |
| Q4 2019 | $59,000 | +1.7% | 39,100 | 0.0% | 0.00% | – |
| Q3 2019 | $58,000 | +16.0% | 39,100 | 0.0% | 0.00% | – |
| Q2 2019 | $50,000 | -51.0% | 39,100 | 0.0% | 0.00% | – |
| Q1 2019 | $102,000 | +56.9% | 39,100 | 0.0% | 0.00% | – |
| Q4 2018 | $65,000 | -65.8% | 39,100 | 0.0% | 0.00% | – |
| Q3 2018 | $190,000 | +153.3% | 39,100 | +225.8% | 0.00% | – |
| Q2 2018 | $75,000 | -25.0% | 12,000 | 0.0% | 0.00% | – |
| Q1 2018 | $100,000 | -18.0% | 12,000 | 0.0% | 0.00% | – |
| Q4 2017 | $122,000 | +10.9% | 12,000 | 0.0% | 0.00% | – |
| Q3 2017 | $110,000 | +25.0% | 12,000 | 0.0% | 0.00% | – |
| Q2 2017 | $88,000 | +2.3% | 12,000 | 0.0% | 0.00% | – |
| Q1 2017 | $86,000 | +16.2% | 12,000 | -4.8% | 0.00% | – |
| Q4 2016 | $74,000 | -14.9% | 12,600 | -4.5% | 0.00% | – |
| Q3 2016 | $87,000 | -34.6% | 13,200 | -7.7% | 0.00% | – |
| Q2 2016 | $133,000 | -16.9% | 14,300 | -3.4% | 0.00% | – |
| Q1 2016 | $160,000 | -29.2% | 14,800 | -6.3% | 0.00% | – |
| Q4 2015 | $226,000 | -31.9% | 15,800 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $332,000 | – | 15,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|